| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | - | 5.088 | 10.329 | 5.091 | 21.787 | 12.583 |
| Total Income - EUR | - | - | - | 0 | - | 5.088 | 10.329 | 5.091 | 21.787 | 12.583 |
| Total Expenses - EUR | - | - | - | 13 | - | 408 | 166 | 395 | 8.938 | 16.098 |
| Gross Profit/Loss - EUR | - | - | - | -13 | - | 4.680 | 10.162 | 4.696 | 12.849 | -3.515 |
| Net Profit/Loss - EUR | - | - | - | -13 | - | 4.533 | 9.872 | 4.598 | 12.631 | -3.640 |
| Employees | - | - | - | 0 | - | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Glucose Infusion S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | - | 0 | 0 | 0 | 0 | 1.558 |
| Current Assets | - | - | - | 43 | - | 10.183 | 19.587 | 5.117 | 13.535 | 10.777 |
| Inventories | - | - | - | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | - | 7.132 | 19.285 | 3.210 | 7.918 | 7.766 |
| Cash | - | - | - | 43 | - | 3.050 | 302 | 1.908 | 5.617 | 3.011 |
| Shareholders Funds | - | - | - | 30 | - | 9.757 | 19.413 | 4.646 | 12.680 | 8.420 |
| Social Capital | - | - | - | 43 | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 13 | - | 425 | 175 | 471 | 855 | 3.915 |
| Income in Advance | - | - | - | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1072 - 1072" | |||||||||
| CAEN Financial Year |
8299
|
|||||||||
Comments - Glucose Infusion S.r.l.